According to Xoma, the new programs add to the multiple discovery and development programs already being advanced through the collaboration. Xoma said that, in collaboration with a number
Under the terms of the partnership, LibraGen will use its proprietary enzyme discovery and development to identify new enzymes for efficient conversion of a large spectrum of ketons
National Institute of Allergy and Infectious Disease (NIAID) is part of the National Institutes of Health (NIH), and its grants are typically given to high-priority NIH programs. The
Under the terms of the amended agreement, EpiCept has granted Durect royalty-free, fully paid up, perpetual and irrevocable rights to the intellectual property licensed as part of the
The new division’s first priority will be to develop over-the-counter wound treatment applications for Oxycyte. Oxycyte is the company’s perfluorocarbon therapeutic oxygen carrier. Dr Diegelmann is a tenured
The transaction was approved by the unanimous vote of Ariad’s independent and disinterested board members, and is effective immediately. Under the terms of the merger agreement, each outstanding
As part of the controlled launch for the AcrySof phakic lens, Alcon will provide surgeons with an integrated and comprehensive training, educational, and support program. Bill Barton, vice
Under the memorandum of understanding (MoU), Siloam Hospitals and Varian have agreed to pursue a collaborative relationship to explore opportunities for developing innovative health solutions for delivering cancer
As a result of this decision, the FDA is no longer enjoined from approving subsequent abbreviated new drug applications. Teva intends to seek a stay of this decision
Mr Trepanier has been serving as interim secretary and CFO since May 2008 and had previously been etrials’s corporate controller and vice president of finance. Prior to joining
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.